Lawrence Kenyon

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Lawrence Kenyon
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lawrence Kenyon:

Company Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. Chief Financial Officer, Director Common Stock 5,946 $33,828 $5.69 26 Sep 2024 Direct
Outlook Therapeutics, Inc. Chief Financial Officer, Director Stock Option (Right to Buy) 12,500 20 Mar 2024 Direct

Insider Reports Filed by Lawrence Kenyon

Symbol Company Period Transactions Value $ Form Type Role Filing Time
OTLK Outlook Therapeutics, Inc. 26 Sep 2024 1 +$28,446 4 Chief Financial Officer, Director 30 Sep 2024, 16:53
OTLK Outlook Therapeutics, Inc. 20 Mar 2024 1 $0 4 CHIEF FINANCIAL OFFICER, Director 22 Mar 2024, 17:00